Ionis Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
26.01.24
/
50%
€47.43
Target price
26.01.25
€64.40
Performance (%)
-24.04%
Price
15.05.24
€36.03
Summary
This prediction is currently active. The prediction for Ionis Pharmaceuticals Inc. disappoints with a performance of -24.04%. This prediction currently runs until 26.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ionis Pharmaceuticals Inc. | -3.586% | -3.586% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target raised by analysts at Royal Bank of Canada from $65.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for IONS provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.75
05.10.23
05.10.23
€61.66
05.10.24
05.10.24
-17.65%
15.05.24
15.05.24